Join Us At ASBrS 2021

A Case-Based Discussion of Integrating MammaPrint® and BluePrint® into Treatment Planning for Patients with Early Stage Breast Cancer


This symposium will feature a case-based discussion of Mammaprint and Blueprint’s clinical utility for patients with Early Stage Breast Cancer. The speakers will discuss real world evidence and published clinical data in the context of patient care. Attendees will participate in an interactive Q&A at the end of the presentation.

Join Us Friday, April 30, 2021 – 9:00 AM- 10:00 AM

Register Now For Friday, April 30th

About the speakers

William Audeh, MD, MS

William Audeh, MD, MS is a medical oncologist specializing in breast cancer, with nearly 30 years of experience as a clinician and clinical researcher at the Cedars-Sinai Cancer Center in Los Angeles. Prior to joining Agendia, and in addition to his clinical practice, he served as the former Director of the Cedars-Sinai Cancer Center and Medical Director of the Wasserman Breast Cancer Risk Reduction Program. Dr. Audeh has been Principal Investigator on a wide variety of national and international clinical and translational trials, and has authored numerous publications in the field of breast cancer, cancer genomics and targeted cancer therapy.

Pat Whitworth, MD

Pat Whitworth, MD is a breast surgical oncologist and Director of the Nashville Breast Center. He has served as Chair of the Board of Directors for the American Society of Breast Surgeons (ASBrS, 2005-2008), Vice Chair of the Breast Committee for the American College of Surgeons Oncology Group (ACOSOG), and Chair of the Research Committee for the ASBrS.


Trusted by leading physicians and institutions around the world

Our Tests

At the genomic level, physicians can examine the activity of specific genes inside a tumor – how they interact to drive the behavior of a tumor.

View More Information
Genomic Testing Cell Photo

Landmark Studies

Data on the validation and utility of MammaPrint and BluePrint for patients with early stage breast cancer.

View More Information
Two women reading about genomic breast cancer results

Latest News

The most recent data and news from Agendia to keep you up-to-date on how our tests can support you and your patients.

Read the article